Marc Carrier/X
Jun 22, 2025, 06:29
Marc Carrier: Therapeutic Anticoagulation Improves Survival in Non-Critical COVID-19
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on X.
“In non-critically ill patients with COVID-19, therapeutic-dose anticoagulation reduced organ support, thrombosis, and death by 28 days, but increased bleeding risk (though absolute risk stayed low).
No high-credibility effect modifiers found.
Great work.”
More ISTH 2025 posts on Hemostasis Today.
-
Oct 10, 2026, 10:55Tzu-Fei Wang: How Should We Approach Anticoagulation in Patients with Cancer-Associated Gonadal and Renal Vein Thrombosis?
-
Oct 10, 2026, 10:50Robert Sidonio Joins ATHN Advanced Clinical Research Fellowship Program
-
Oct 10, 2026, 10:45Federica Fogacci: Co-Moderating at CA Meet 2026 in Padua – Elevating Lifestyle Interventions in Cardiology
-
Oct 10, 2026, 10:40Juan Cristóbal Morales Muñoz: Pharmacokinetic Profiling of Factor VIII Concentrates in Chilean Patients
-
Oct 10, 2026, 10:32Randall Schaefer: When Your Prehospital Agency Reports Blood Product Wastage Rates, What is it Really Reporting?
-
Oct 10, 2026, 10:26Simone Strasser: ROTEM-Guided Transfusion Cuts Blood Product Use in Patients with Cirrhosis
-
Oct 10, 2026, 10:18Jérôme S.: WHO Launches Global Roadmap to Combat Hypertensive Disorders of Pregnancy
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India